siRNA, Anti-COL12A1, 2'-F/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT02885WQ-2F)
The product SIRGT02885WQ-2F is a type of small interfering RNA (siRNA) that targets COL12A1 gene and regulates the expression of gene. The siRNA interferes with the expression of COL12A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-deoxy-2ʹ-fluoro (2'-F) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.
| Specifications | |
|---|---|
| NCBI RefSeq | NM_004370.5; NM_080645.2 |
| Alternative Names | BA209D8.1; BTHLM2; COL12A1L; DJ234P15.1; UCMD2 |
| Related Diseases | Bethlem Myopathy, Ullrich Congenital Muscular Dystrophy |
| Purification | HPLC |
| Sub Cat | Target | Species | Modification | Scale | |
|---|---|---|---|---|---|
| SIRGT03885WQ-2MOE | COL12A1 | Human | 2'-O-methoxyethyl (2'-MOE) | ||
| SIRGT04885WQ-LNA | COL12A1 | Human | Locked Nucleic Acid (LNA) | ||
| SIRGT01885WQ-RB | COL12A1 | Human | Ribo-modified | ||
| SIRGT02885WQ-BB | COL12A1 | Human | Backbone-modified |
